Canada markets closed

Shin Nippon Biomedical Laboratories, Ltd. (YB3.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
7.95-0.30 (-3.64%)
At close: 08:15AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 353.10M
Enterprise Value 446.72M
Trailing P/E 10.33
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.16
Price/Book (mrq)1.67
Enterprise Value/Revenue 0.02
Enterprise Value/EBITDA 0.05

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-44.63%
S&P500 52-Week Change 326.43%
52 Week High 315.60
52 Week Low 37.95
50-Day Moving Average 39.00
200-Day Moving Average 310.64

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 541.63M
Implied Shares Outstanding 642.8M
Float 820.22M
% Held by Insiders 151.20%
% Held by Institutions 120.09%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.3
Forward Annual Dividend Yield 43.65%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 41.34
Payout Ratio 437.63%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 27, 2024
Last Split Factor 22:1
Last Split Date 3Sept 27, 2005

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 20.91%
Operating Margin (ttm)19.22%

Management Effectiveness

Return on Assets (ttm)3.90%
Return on Equity (ttm)18.24%

Income Statement

Revenue (ttm)26.45B
Revenue Per Share (ttm)635.33
Quarterly Revenue Growth (yoy)-2.90%
Gross Profit (ttm)N/A
EBITDA 5.76B
Net Income Avi to Common (ttm)5.53B
Diluted EPS (ttm)0.80
Quarterly Earnings Growth (yoy)1.60%

Balance Sheet

Total Cash (mrq)10.61B
Total Cash Per Share (mrq)254.84
Total Debt (mrq)26.19B
Total Debt/Equity (mrq)76.66%
Current Ratio (mrq)1.31
Book Value Per Share (mrq)819.34

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A